Status:
COMPLETED
Effect of Different Probiotic Strains in Hypercholesterolemic Patients
Lead Sponsor:
Eastern Mediterranean University
Conditions:
Hyperlipidemias
Eligibility:
All Genders
19-65 years
Phase:
NA
Brief Summary
Regular probiotic use for 8 weeks was evaluated in individual with mild to moderate hyperlipidemia. Current study have been determined the use of different probiotics strains on lipid parameters such ...
Detailed Description
In the light of recent studies, it has been shown that probiotics may have positive effects on hyperlipidemia. The aim of this study was to investigate the effect of probiotics mainly on blood lipids ...
Eligibility Criteria
Inclusion
- • Had a repeated total cholesterol level ≥200 mg/dL prior to allocate to the study group and to declined conventional lipid lowering medical treatment
Exclusion
- Those with any chronic conditions other than hypercholesterolemia,
- Individuals with inherited lipid metabolic disorders,
- Individuals with chronic gastrointestinal disease,
- Individuals with immunodeficiency,
- Individuals with malignancy,
- Individuals with mental disabilities,
- Patients currently using any lipid lowering drugs, or an alternative treatment to lower blood cholesterol (such as probiotics) and individuals who have used antibiotics in the previous three months prior to study and
- Pregnant or lactating women were excluded from the study.
Key Trial Info
Start Date :
September 28 2018
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 7 2019
Estimated Enrollment :
51 Patients enrolled
Trial Details
Trial ID
NCT04701775
Start Date
September 28 2018
End Date
March 7 2019
Last Update
January 12 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Gözde Okburan
Famagusta, Cyprus